Aurenar, a BioGenerator portfolio company and Washington University startup, has received FDA Breakthrough Device Designation for its non-invasive V-Link System, an earbud-like device designed to reduce life-threatening complications following a brain bleed. The technology has shown promising early results in reducing inflammation, improving patient outcomes, and lowering ICU costs, bringing it one step closer to helping critically ill stroke patients.
Read More at